• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠支架报告不良事件分析:一项FDA MAUDE数据库研究

Analysis of Reported Adverse Events With Colonic Stents: An FDA MAUDE Database Study.

作者信息

Ramai Daryl, DeLuca Matthew, Facciorusso Antonio, Ofosu Andrew, Girotra Mohit, Tabibian James H, Rodrigues-Pinto Eduardo, Adler Douglas G, Barakat Monique T

机构信息

Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT.

Section of Gastroenterology, Department of Medical Sciences, University of Foggia, Foggia, Italy.

出版信息

J Clin Gastroenterol. 2022 Oct 1;56(9):784-786. doi: 10.1097/MCG.0000000000001632. Epub 2021 Dec 15.

DOI:10.1097/MCG.0000000000001632
PMID:34907923
Abstract

BACKGROUND

Colonic stents are indicated for preoperative and palliative decompression of large bowel obstruction. We aim to investigate post Food and Drug Administration (FDA) approval outcomes associated with colonic stents.

MATERIALS AND METHODS

We analyzed postmarketing surveillance data from the FDA Manufacturer and User Facility Device Experience (MAUDE) database from January 2011 to December 2020.

RESULTS

During the study period, 691 device issues and 742 patient complications were identified. The number of adverse events reported to the FDA mildly increased from 6.40% in 2011 to 7.4% in 2020. Most device complications were due to a positioning problem (n=201, 29%), followed by device break (n=60, 8.6%), delamination (n=41, 6.3%), and migration or expulsion device (n=38, 5.55%). A number of reports described an unclassified adverse event without specifying device or operator problem (n=141, 20.3%). The most reported patient adverse events were perforation (n=150, 20.1%), death (n=47, 6.3%), abdominal pain/discomfort (n=27, 3.6%), and peritonitis (n=24, 3.2%).

CONCLUSION

Findings from the MAUDE database highlight rare but important patient and device complications which endoscopists and referring providers should be aware of before consideration for colonic stent placement.

摘要

背景

结肠支架适用于大肠梗阻的术前和姑息性减压。我们旨在研究美国食品药品监督管理局(FDA)批准后与结肠支架相关的结果。

材料与方法

我们分析了2011年1月至2020年12月期间FDA制造商和用户设施设备经验(MAUDE)数据库的上市后监测数据。

结果

在研究期间,共识别出691起设备问题和742例患者并发症。向FDA报告的不良事件数量从2011年的6.40%略有增加到2020年的7.4%。大多数设备并发症是由于定位问题(n = 201,29%),其次是设备断裂(n = 60,8.6%)、分层(n = 41,6.3%)和移植物迁移或排出(n = 38,5.55%)。许多报告描述了未分类的不良事件,但未具体说明设备或操作者问题(n = 141,20.3%)。报告最多的患者不良事件是穿孔(n = 150,20.1%)、死亡(n = 47,6.3%)、腹痛/不适(n = 27,3.6%)和腹膜炎(n = 24,3.2%)。

结论

MAUDE数据库的研究结果突出了罕见但重要的患者和设备并发症,内镜医师和转诊提供者在考虑放置结肠支架之前应予以关注。

相似文献

1
Analysis of Reported Adverse Events With Colonic Stents: An FDA MAUDE Database Study.结肠支架报告不良事件分析:一项FDA MAUDE数据库研究
J Clin Gastroenterol. 2022 Oct 1;56(9):784-786. doi: 10.1097/MCG.0000000000001632. Epub 2021 Dec 15.
2
Adverse Events and Device Failures Associated with Pancreatic Stents: A Comprehensive Analysis Using the FDA's MAUDE Database.与胰腺支架相关的不良事件和器械故障:利用 FDA 的 MAUDE 数据库进行的全面分析。
Dig Dis Sci. 2024 Jun;69(6):2018-2025. doi: 10.1007/s10620-024-08396-8. Epub 2024 Apr 5.
3
A Comprehensive Analysis of Reported Adverse Events and Device Failures Associated with Esophageal Self-Expandable Metal Stents: An FDA MAUDE Database Study.食管自膨式金属支架不良事件和器械故障的综合分析:FDA MAUDE 数据库研究。
Dig Dis Sci. 2024 Aug;69(8):2765-2774. doi: 10.1007/s10620-024-08483-w. Epub 2024 May 29.
4
Trends and incidence of reported events associated with ureteral stents: an analysis of the food and drug administration's manufacturer and user facility device experience (MAUDE) database.与输尿管支架相关的报告事件的趋势和发生率:对食品和药物管理局的制造商和用户设施设备体验(MAUDE)数据库的分析。
World J Urol. 2024 Sep 14;42(1):524. doi: 10.1007/s00345-024-05225-5.
5
Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation.对美国食品药品监督管理局制造商及用户设施设备经验数据库中涉及体外膜肺氧合的患者及回路相关不良事件的分析。
Cardiovasc Revasc Med. 2020 Feb;21(2):230-234. doi: 10.1016/j.carrev.2019.11.011. Epub 2019 Nov 20.
6
Adverse events associated with AXIOS stents: Insights from the manufacturer and user facility device experience database.与AXIOS支架相关的不良事件:来自制造商和用户机构设备经验数据库的见解
Endosc Ultrasound. 2022 May-Jun;11(3):231-236. doi: 10.4103/EUS-D-21-00096.
7
Patient-related adverse events and device failures associated with commercially available enteral or duodenal self-expanding metal stents: an analysis of the MAUDE database.与市售肠内或十二指肠自膨式金属支架相关的与患者相关的不良事件和器械故障:MAUDE 数据库分析。
Gastrointest Endosc. 2023 Feb;97(2):309-313. doi: 10.1016/j.gie.2022.10.008. Epub 2022 Oct 8.
8
Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database.与 FilterWire EZ 栓塞保护系统相关的不良事件和失败模式:从 FDA MAUDE 数据库的分析审查中吸取的教训。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):157-164. doi: 10.1002/ccd.28297. Epub 2019 Apr 15.
9
Analysis of Reported Adverse Events Associated with Over-the-Scope Endoscopic Suturing System: an FDA MAUDE Database Study.与内镜套扎缝合系统相关的报告不良事件分析:一项美国食品药品监督管理局不良事件报告系统数据库研究
Obes Surg. 2023 Apr;33(4):1253-1258. doi: 10.1007/s11695-023-06525-2. Epub 2023 Feb 21.
10
Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.美国食品和药物管理局医疗器械不良事件报告中除死亡以外其他类别的死亡报告情况。
JAMA Intern Med. 2021 Sep 1;181(9):1217-1223. doi: 10.1001/jamainternmed.2021.3942.

引用本文的文献

1
Perforation that Occurred Right After Sigmoid Colon Cancer Stenting.
Dig Dis Sci. 2025 Sep 8. doi: 10.1007/s10620-025-09382-4.
2
Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data.基于食品和药物管理局制造商和用户设施设备经验数据评估研究的可重复性。
J Patient Saf. 2024 Aug 1;20(5):e45-e58. doi: 10.1097/PTS.0000000000001220. Epub 2024 Mar 12.